论文部分内容阅读
科技日报电,从4月9日在京召开的第五届清华脑起搏器论坛上获悉:我国自主研发的脑起搏器已经造福3 500多例帕金森患者,为患者累计节省治疗费用超过2亿元。帕金森是一种常见的退行性神经系统疾病。从1997年开始,每年的4月11日被定为是世界帕金森病日。据统计,我国50岁以上老年人的患病率约1%,全国约有帕金森病患者200万人。脑起搏器手术(DBS)被国际公认为治疗帕金森的最佳神
Science and Technology Daily News, from April 9 in Beijing held the fifth session of the Tsinghua Pacemaker was informed that: China’s independent research and development of pacemakers have benefited more than 3,500 Parkinson’s patients, patients with cumulative savings in treatment costs over 2 100 million yuan. Parkinson is a common degenerative neurological disease. Since 1997, April 11 of each year has been designated as World Parkinson’s Day. According to statistics, the prevalence of the elderly over 50 in China is about 1%, and there are about 2 million people in the country with Parkinson’s disease. Brain pacemaker surgery (DBS) is internationally recognized as the best God to treat Parkinson’s